Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  07/28/2010
 
Trade Name:  Lastacaft Ophthalmic Solution
 
Generic or Proper Name (*):  alcaftadine
 
Indications Studied:  Prevention of itching associated with allergic conjunctivitis.
 
Therapeutic Category:  Antihistamine, topical
 
Ages Studied:  Children >2 years old
 
Study #:  5
 
Study Type:  Efficacy/Safety
 
Study Design:  Single-Blind/Placebo/Parallel Group
 
No Patients:  27
 
No Centers:  14
 
No Countries:  1
 
BPCA(B), PREA(P):  P
 
-
-